We are live on ! Find out more
FQ

First Quadrant Portfolio holdings

AUM $18M
1-Year Est. Return 24.2%
This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+24.2%
3 Year Est. Return
+90.61%
5 Year Est. Return
+144.39%
10 Year Est. Return
–
AUM
$4.49B
AUM Growth
+$87.2M
Cap. Flow
-$70.7M
Cap. Flow %
-1.57%
Top 10 Hldgs %
16.01%
Holding
859
New
109
Increased
142
Reduced
182
Closed
54

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$26.9M
2
ELV icon
Elevance Health
ELV
+$26.5M
3
GILD icon
Gilead Sciences
GILD
+$20M
4
ZBRA icon
Zebra Technologies
ZBRA
+$18.8M
5
JNJ icon
Johnson & Johnson
JNJ
+$18M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$27.8M
2
PKG icon
Packaging Corp of America
PKG
+$25.4M
3
AMGN icon
Amgen
AMGN
+$21.4M
4
HSY icon
Hershey
HSY
+$20.5M
5
EIX icon
Edison International
EIX
+$19.8M

Sector Composition

Rank Sector Weight
1 Financials 16.39%
2 Technology 15.39%
3 Healthcare 14.54%
4 Industrials 13.38%
5 Energy 11.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMZN icon
326
Amazon
AMZN
$2.68T
$1.65M 0.04%
101,560
-348,000
-77% -$5.51M
R icon
327
Ryder
R
$9.25B
$1.64M 0.04%
18,600
– –
EXPO icon
328
Exponent
EXPO
$3.2B
$1.63M 0.04%
88,000
-3,600
-4% -$64.3K
VC icon
329
Visteon
VC
$2.61B
$1.63M 0.04%
16,791
– –
EIX icon
330
Edison International
EIX
$21B
$1.58M 0.04%
27,200
-353,200
-93% -$19.8M
IQNT
331
DELISTED
Inteliquent, Inc.
IQNT
$1.58M 0.04%
113,900
-3,000
-3% -$43.8K
FRX
332
DELISTED
FOREST LABORATORIES INC
FRX
$1.52M 0.03%
+15,400
New +$1.44M
SO icon
333
Southern Company
SO
$98.9B
$1.5M 0.03%
33,087
+14,024
+74% +$620K
FMER
334
DELISTED
FIRSTMERIT CORP
FMER
$1.5M 0.03%
75,898
-102
-0.1% -$2K
MOG.A icon
335
Moog Inc Class A
MOG.A
$11.3B
$1.48M 0.03%
20,300
– –
WNR
336
DELISTED
Western Refining Inc
WNR
$1.48M 0.03%
39,306
– –
VAR
337
DELISTED
Varian Medical Systems, Inc.
VAR
$1.42M 0.03%
19,531
– –
AFSI
338
DELISTED
AmTrust Financial Services, Inc.
AFSI
$1.41M 0.03%
67,600
+1,000
+2% +$20.5K
LIN
339
DELISTED
LIN MEDIA LLC CLASS A COM
LIN
$1.4M 0.03%
51,491
-3,190
-6% -$80.2K
IGTE
340
DELISTED
IGATE CORPORATION
IGTE
$1.38M 0.03%
37,900
-8,600
-18% -$301K
LFUS icon
341
Littelfuse
LFUS
$10B
$1.37M 0.03%
14,700
– –
LSTR icon
342
Landstar System
LSTR
$5.86B
$1.36M 0.03%
21,332
– –
MCD icon
343
McDonald's
MCD
$179B
$1.33M 0.03%
13,244
– –
FFIV icon
344
F5
FFIV
$24.4B
$1.33M 0.03%
11,900
+3,900
+49% +$420K
ISRG icon
345
Intuitive Surgical
ISRG
$133B
$1.32M 0.03%
28,800
-81
-0.3% -$3.57K
AGN
346
DELISTED
Allergan plc
AGN
$1.31M 0.03%
5,883
+3,376
+135% +$699K
FL
347
DELISTED
Foot Locker
FL
$1.29M 0.03%
+25,500
New +$1.22M
COF icon
348
Capital One
COF
$127B
$1.29M 0.03%
15,600
– –
FIBK icon
349
First Interstate BancSystem
FIBK
$3.57B
$1.26M 0.03%
46,400
+3,000
+7% +$78.5K
MRC
350
DELISTED
MRC Global
MRC
$1.25M 0.03%
+44,100
New +$1.25M
12 13
14
15 16

Similar funds

ICMH
Integrity Capital Management (HK) Central, Hong Kong $19.4M AUM
BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return
SCM
SunTx Capital Management Dallas, Texas $21.3M AUM 12.38% 1-Year Est. Return
CFG
Claremont Financial Group Claremont, California $23.4M AUM
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
YEPV
Yorktown Energy Partners V New York $5.41M AUM
WIA
Wealthstreet Investment Advisors Dallas, Texas $3.71M AUM 13.1% 1-Year Est. Return
LSM
Light Sky Macro New York $1.34M AUM

First Quadrant's Q2 2014 Portfolio in Review

As of Q2 2014, First Quadrant held 859 positions worth $4.49B, up 2% from $4.41B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

First Quadrant's Q2 2014 filing shows 109 new, 142 increased, 182 reduced and 54 closed positions. Its largest new stake was Harley-Davidson: 252,500 shares worth $17.6M. The largest sale was Biogen, an estimated $27.8M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • First Quadrant's largest Q2 2014 buy was Harley-Davidson: 252,500 shares worth $17.6M.
  • First Quadrant added most to Merck in Q2 2014, an estimated $26.9M increase.
  • First Quadrant's biggest Q2 2014 reduction was Biogen, cutting an estimated $27.8M.
  • First Quadrant fully exited BALLY TECHNOLOGIES, INC. in Q2 2014, selling an estimated $14.7M.
  • First Quadrant's ten largest holdings make up 16% of its $4.49B portfolio in Q2 2014.
  • First Quadrant opened 109 new positions and closed 54 in Q2 2014.
  • First Quadrant's portfolio value rose 2% quarter-over-quarter to $4.49B.

Based on First Quadrant's 13F filing for Q2 2014, filed 31 Jul 2014.